BUAD820 – Case 2 Merck Case Decision Tree and Analysis Presented By – Sridevi Chennuri Nuray Coban Subhashini Reddy Merck & Company :Evaluating a Drug Licensing Opportunity • Background - Merck & Company : •In 2000‚ it was a global research-driven pharmaceutical company that discovers‚ develop‚ manufactures and markets a broad range of human and animal health products‚ directly and through its joint ventures‚ and provides pharmaceutical benefit management services through Merck-Medco Managed Care
Premium Clinical trial Decision tree Expected value
The first international meeting to discuss illicit drugs was in 1909‚ at the Shanghai Opium Commission. This led to the first drug control treaty‚ the International Opium Convention of the Hague‚ which resulted in an 80% drop in opium production and consumption. Since then‚ multiple significant resolutions have been passed to regulate and prevent drug trafficking. Resolution #67/193 emphasizes need for better rehabilitation of drug addicts and also called for complete cooperation and unification
Premium Drug addiction Drug Heroin
The Oceanic Corporation (Determining the Cost of Capital) Larry Stone wants to estimate the firm’s hurdle rate because it is a benchmark for how well the company needs to do on a project in order to at least break even. The higher the hurdle rate‚ the riskier the project will have to be and the lower the hurdle rate is‚ the safer the project will be for a company. A company should strive for a financing mix that minimizes the hurdle rate and matches the assets being financed. If there
Premium Marketing United States Balance sheet
invest their money they need to earn a rate of return that exceeds their cost of capital. We can estimate a company’s cost of capital in the following way: WACC = (rD)(1-T)(WD) + (rS)(WS) Go to one of the databases from Part 1 of the Course Project and look up the most recent 10-K for your company‚ paying special attention to the balance sheet and the footnotes. Although we should use market value weights when determining a firm’s cost of capital‚ this may be difficult to determine for a firm
Premium
we estimated the weighted average cost of capital of the AMD and Duke Energy. For the AMD‚ the WACC is 10.83%. For Duck Energy‚ the WACC is 2.76% When we calculate those number‚ we need to know the equity and debt of the company which can easily find on yahoo finance. The cost of debt and the corporate tax rate that we calculated are also based on the data from yahoo finance. We made Beta for the companies with 10 year ranges and use it to calculate return of equity. After we got those number
Premium Finance Weighted average cost of capital Investment
Case Study: Merck Acquisition of Medco Professor Daniel Weiss FI561 January 23‚ 2011 Case Study: Merck Acquisition of Medco Abstract The purpose of this case study is to determine whether it would be beneficial to merge Merck Corporation with Medco Containment Services Incorporated. The merger and acquisition between the world’s largest drug manufacturer and the largest prescription benefits management company (PBM) and marketer of mail order medicines in the United States would result
Premium Mergers and acquisitions Due diligence
Merck SWOT Analysis MGT/521 July 25‚ 2012 Merck SWOT Analysis Company Overview Merck is the 2nd largest pharmaceutical company in world offering prescription medications‚ biologics‚ vaccines‚ animal health‚ and consumer care products. It generated 48 billion dollars in revenue in 2011 and has 40‚000 employees. Research and development of proprietary medicines for global marketing is the core of the business. Recent acquisitions and transactions designed to take advantage
Premium Management Strategic management Marketing
Case analysis "Cost of Capital at Ameritrade" Cost of capital refers to the maximum rate of return a company must earn from its investments‚ so that the market values of the company’s equity shares do not go down. The people at Ameritrade are not in agreement on the best estimate of the cost of capital. Research analyst put the cost of capital at 12%‚ while other members of the management estimate it to be at 9% and the CFO estimates it to be at 15%. The CEO of the company is optimistic that
Premium Investment Finance Stock market
MGT 4083-Technology Strategy Case Analysis Merck & Co.: Evaluating a Drug Licensing Opportunity Introduction: Davanrik is a new drug developed by LAB Pharmaceuticals‚ which has the potential to treat depression and obesity. Davanrik was initially developed to treat depression by stimulating the receptor in the serotonin system that promotes anti-depression. However‚ it was discovered that Davanrik also blocks the receptor that causes hunger. LAB Pharmaceuticals obtained a patent for Davanrik
Premium
PRACTICES” IN ESTIMATING THE COST OF CAPITAL: AN UPDATE 15 “Best Practices” in Estimating the Cost of Capital: An Update W. Todd Brotherson‚ Kenneth M. Eades‚ Robert S. Harris‚ and Robert C. Higgins “Cost of capital is so critical to things we do‚ and CAPM has so many holes in it—and the books don’t tell you which numbers to use… so at the end of the day‚ you wonder a bit if you’ve got a solid number. Am I fooling myself with this Theories on cost of capital have been around for decades
Premium Arithmetic mean Interest Weighted average cost of capital